Another cost-effectiveness analysis published in JMCP found that tirzepatide 15 mg produced greater quality-adjusted life-years (QALYs) and delayed progression to insulin, with incremental cost-effectiveness ratios (ICERs) of about USD 54,700/QALY (15 mg) and USD 70,100/QALY (10 mg) vs semaglutide 2.0 mg
Persistent Opioid Use After Hospital Admission From Surgery in New Zealand: A Population-Based Study Anesth Analg 2024;139:70110) Outcomes Related to New Persistent Opioid Use After Surgery or Trauma A Population-based Cohort Study (Ann Surg 2025;281:354360) IF YOU DONT MEASURE YOU CANT IMPROVE
In practice, the differences between semaglutide, tirzepatide, and retatrutide could mean 10 extra pounds lost, fewer side effects, or access to a medication that does not even exist on pharmacy shelves yet
It is used to treat and prevent vitamin deficiencies in patients unable to take oral medications
Other contraindications include uncontrolled thyroid disease, active pituitary disorders, and pregnancy
While the timeline for seeing results varies from person to person, there are general trends that most people experience